COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 30: Articles 291-300  | Next

Real-world effectiveness of NVX-CoV2373 COVID-19 vaccine in immunocompromised individuals in South Korea
Gwak, E., Choe, S.-A., Kim, K., Bolormaa, E., Gschwend, M. H., Fix, J., Vadivale, M., Rousculp, M. D., Choe, Y. J.
10.1101/2025.04.24.25326359 — Posted: 2025-04-25
Must Whatever Goes up Come Down? Mortality Gradients in the Emergence of COVID-19
Klein, J. D.
10.1101/2025.04.23.25326307 — Posted: 2025-04-25
Healthcare use in individuals with rheumatoid arthritis during the COVID-19 pandemic and beyond: A cohort study in three nations of the UK
Costello, R. E., Parker, M., Kennedy, J., Brophy, S., Mehrkar, A., Bacon, S., Goldacre, B., MacKenna, B., Evans, D., Tomlinson, L., Hollick, R., Humphreys, J.
10.1101/2025.04.25.25326408 — Posted: 2025-04-25
Spatiotemporal structure of SARS-CoV-2 mutational frequencies in wastewater samples from Ontario
Magbor, P., Wang, W. Z., Gugan, G., Olabode, A. S., Becker, D. G., Parreira, V. R., Lawal, O. U., Fedynak, A., Zhang, L., Rizvi, F., Precious, M., DeGroot, C. T., Goodridge, L., Poon, A. F. Y.
10.1101/2025.04.23.25326084 — Posted: 2025-04-25
Impact of self-administered pulse oximetry among non-hospitalized patients at risk of severe COVID-19 in Honduras: A pragmatic, block-randomized trial
Roberts, K. W., Alvarez, B., de St. Aubin, M., Diaz, O., Garnier, S., Schnorr, C. D., Cruz, S., Pavon, L., Ochoa, A., Medice, S., Santos, H. M., Ochoa, J., Solis, S., Dumas, D., Baldwin, M., Martinez, A., Nilles, E.
10.1101/2025.04.23.25326278 — Posted: 2025-04-25
Transmission dynamics of Norovirus GII and Enterovirus in Switzerland during the COVID-19 pandemic (2021-2022) as evidenced in wastewater
Huisman, J. S., Torii, S., Wynn, H. K., Gan, C., Voellmy, I. K., Huber, M., Julian, T. R., Kohn, T.
10.1101/2025.04.22.25326216 — Posted: 2025-04-24
K5 polysaccharides inhibit SARS-CoV-2 infection by preventing spike-proteolytic priming
Milanesi, M., Urbinati, C., Zimmermann, L., Oreste, P., Zani, A., Caruso, A., Caccuri, F., Laketa, V., Chlanda, P., Wade, R. C., Rusnati, M., Paiardi, G.
10.1101/2025.04.23.650164 — Posted: 2025-04-24
COVID-19 in Space: Possible Health Risks and Preparedness Guidelines
Vashishat, I., Han, E., Assogba, B. D.
10.1101/2025.04.23.650113 — Posted: 2025-04-24
In Vitro and Viral Evolution Convergence Reveal the Selective Pressures Driving Omicron Emergence
Shoshany, A., Tian, R., Blanco, M. P., Hruska, A., Konar, A., Baxova, K., Zoler, E., Mokrejs, M., Schreiber, G., Zahradnik, J.
10.1101/2025.04.23.650148 — Posted: 2025-04-24
Characterization of betacoronavirus HKU-1 and OC43 internal proteins using a prototypic coronavirus
Gunawardene, C. D., Pandey, I., Chatterjee, S., Penaflor-Tellez, Y., Odle, A., Messyasz, A., Rajsbaum, R., Sariol, A., Wong, L.-Y. R.
10.1101/2025.04.23.650176 — Posted: 2025-04-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).